C-peptide levels predict type 2 diabetes remission after bariatric surgery;El péptido C predice la remisión de la diabetes mellitus tipo 2 tras cirugía bariátrica

Nutricion Hospitalaria

Volumn 28, Issue 5, 2013, Pages 1599-1603

  Ramos Leví, Ana M ^a   Matía, Pilar ^a   Cabrerizo, Lucio ^a   Barabash, Ana ^a   Torrejón, María José ^a   Sánchez Pernaute, Andrés ^a   Torres, Antonio J ^a   Rubio, Miguel A ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Bariatric surgery; C peptide; Diabetes mellitus; Metabolic surgery; Type 2 diabetes mellitus

Indexed keywords

BIOLOGICAL MARKER; C PEPTIDE;

ARTICLE; BARIATRIC SURGERY; BLOOD; FEMALE; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; REMISSION; RETROSPECTIVE STUDY;

BARIATRIC SURGERY; BIOLOGICAL MARKERS; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; REMISSION INDUCTION; RETROSPECTIVE STUDIES;

EID: 84887913297     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2013.28.5.6554     Document Type: Article

References (17)

1. Dixon JB, le Roux CW, Rubino F, Zimmet P. Bariatric surgery for type 2 diabetes. Lancet 2012; 379: 2300-11.
2. Dixon JB, Zimmet P, Alberti KG, Rubino F. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med 2011; 28: 628-42.
3. American Diabetes Association. Standards of medical care in diabetes 2013 (Position Statement). Diabetes Care 2013; 36 (Suppl. 1): S11-66.
4. Hall TC, Pellen MG, Sedman PC, Jain PK. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg 2010; 20: 1245-50.
5. Hamza N, Abbas MH, Darwish A, Shafeekb Z, Newa J, Ammori BJ. Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis 2011; 7: 691-6.
6. Dixon JB, Chuang LM, Chong K, Chen SC, Lambert GW, Straznicky NE et al. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care 2013; 36: 20-6.
7. Berber B, Stenstrom G, Sundkvist G. Random C-peptide in the classification of diabetes. Scand J Clin Lab Invest 2000; 60: 687-94.
8. Lee WJ, Chong K, Ser KH, Chen JC, Lee YC, Chen SC et al. C-peptide predicts the remission of type 2 diabetes after bariatric surgery. Obes Surg 2012; 22: 293-8.
9. Lee WJ, Chong K, Chen JC et al. Predictors of diabetes remission after bariatric surgery in Asia. Asian J Surg 2012; 35: 67-73.
10. American Diabetes Association. Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care 2013; 36 (Suppl. 1): S67-74.
11. Deitel M, Greenstein RJ. Recommendations for reporting weight loss. Obes Surg 2003; 13: 59-60.
12. Buse JB, Caprio S, Cefalu WT et al. How do we define cure of diabetes? Diabetes Care 2009; 32: 2133-5.
13. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467-84.
14. Lee WJ, Hur KY, Lakadawala M, Kasama K, Wong SK, Chen SC et al. Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis; 2012 Aug 6. [Epub ahead of print]
15. Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care 2008; 31: S290-6.
16. Little RR, Rohlfing CL, Tennill AL, Madsen RW, Polonsky KS, Myers GL et al. Standardization of C-peptide measurements. Clin Chem 2008; 54: 1023-6.
17. Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 2010; 61: 393-411.